TOLERABILITY AND RENAL SPARING OF MYCOPHENOLATE MOFETIL MMF/SIROLIMUS (SRL) MAINTENANCE THERAPY IN LIVER TRANSPLANT RECIPIENTS: 12-MONTH RESULTS OF THE SPARE-THE-NEPHRON (STN) TRIAL

被引：0
|
作者：
Teperman, L. [1 ]
Marotta, P. [2 ]
Sher, L. [3 ]
Sebastian, A. [4 ]
Moonka, D. [5 ]
Patel, D. [6 ]
Koneru, B. [7 ]
机构：
[1] NYU, New York, NY USA
[2] London Hlth Sci Hosp, London, ON, Canada
[3] Univ So Calif, Los Angeles, CA USA
[4] Integris Baptist Med Ctr, Oklahoma City, OK USA
[5] Henry Ford Hosp, Detroit, MI 48202 USA
[6] Roche, Nutley, NJ USA
[7] UMDNJ, Newark, NJ USA
来源：
LIVER TRANSPLANTATION | 2008年 / 14卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S224 / S224
页数：1
相关论文
共 46 条
  • [41] Efficacy and safety of enteric-coated mycophenolate sodium in de novo renal transplant recipients: Results of a 12-month mulitcentre, open-label, prospective study.
    Vitko, S
    Vogt, B
    Antoniadis, A
    Klinger, M
    Kirchher, B
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 191 - 192
  • [42] Maintained efficiacy with steroid minimization in pediatric liver transplant recipients with basiliximab (simulect) induction therapy: A German multicenter randomized 12-month trial.
    Ganschow, Rainer
    Melter, Michael
    Wallot, Michael
    Schulz, Andrea
    Pfister, Eva D.
    Baumann, Ulrich
    Auth, Marcus K. H.
    Fischer, Wolfgang H.
    Burdelski, Martin
    [J]. PEDIATRIC TRANSPLANTATION, 2007, 11 : 36 - 36
  • [43] Everolimus with reduced-exposure cyclosporine versus MMF and standard-exposure cyclosporine in de novo cardiac transplant recipients: 12-month results from a multicenter, Randomized trial
    Arizon, Jose
    Lehmkuhl, Hans
    Livi, Ugolino
    Vigano, Mario
    Branzi, Angelo
    Almenar, Luis
    Gerosa, Gino
    Musumeci, Francesco
    Vamous, Shaida
    Maccherini, Massimo
    Hexham, Mark
    Mange, Kevin C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 211 - 211
  • [44] A randomized, open-label study to compare the safety and efficacy of two different sirolimus (SRL) regimens with a tacrolimus (TAC) and mycophenolate mofetil regimen (MMF) in De novo renal allograft recipients: Acute rejection and graft survival results from the orion study
    Flechner, Stuart
    Glyda, Maciej
    Steinberg, Steven
    Harler, Mary Beth
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 209 - 210
  • [45] Cyclic photodynamic therapy delays first onset of actinic keratoses in renal transplant recipients: a 5-year randomized controlled trial with 12-month follow-up
    Togsverd-Bo, K.
    Sandberg, C.
    Helsing, P.
    Mork, G.
    Wennberg, A. M.
    Wulf, H. C.
    Haedersdal, M.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (11) : E946 - E948
  • [46] Results of a 12 month multicenter trial investigating the kinetics of MPA and MPA-metabolites and the efficacy and side-effect profile of mycophenolate mofetil in renal transplant patients in view of MPA and MPA-metabolites.
    Kuypers, DRJ
    Vanrenterghem, Y
    Squifflet, JP
    Mourad, M
    Abramowicz, D
    Oellerich, H
    Armstrong, V
    Shipkova, M
    Daems, J
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 367A - 368A
12345